Linfeng Xiao, Xiaowei Chang, Jun Zhang, Yinshan Hong, Wenhui Cao, Zhewu Zhao et al. Mitochondria‐targeted nanomedicine for cancer therapy: Targeting strategies, therapeutic mechanisms, and translational challenges. // Interdisciplinary Medicine. – 2026. – DOI: 10.1002/inmd.70166. – URL: https://onlinelibrary.wiley.com/doi/10.1002/inmd.70166?af=R
Linfeng Xiao, Xiaowei Chang, Jun Zhang, Yinshan Hong, Wenhui Cao, Zhewu Zhao, Yu‐E. Wang, & Yanling Yang (2026). Mitochondria‐targeted nanomedicine for cancer therapy: Targeting strategies, therapeutic mechanisms, and translational challenges. Interdisciplinary Medicine. https://doi.org/10.1002/inmd.70166
Linfeng Xiao, et al. “Mitochondria‐targeted nanomedicine for cancer therapy: Targeting strategies, therapeutic mechanisms, and translational challenges.” Interdisciplinary Medicine, 2026. doi:10.1002/inmd.70166.
@article{Xiao2026,
title = {Mitochondria‐targeted nanomedicine for cancer therapy: Targeting strategies, therapeutic mechanisms, and translational challenges},
author = {Xiao, Linfeng and Chang, Xiaowei and Zhang, Jun and Hong, Yinshan and Cao, Wenhui and Zhao, Zhewu and Wang, Yu‐E. and Yang, Yanling},
journal = {Interdisciplinary Medicine},
year = {2026},
doi = {10.1002/inmd.70166},
url = {https://onlinelibrary.wiley.com/doi/10.1002/inmd.70166?af=R}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...